Responsibility
Responsibility
Thriving with Our Shared Community & Environment in Mind
At Kent-Athlone Pharma Group, we are guided by our vision to set a standard in excellence with quality products and services to our partners. We realise this vision by putting compliance first, every time. Our EcoVadis Gold medal accreditation is a testament to the integration of international sustainability standards and corporate social responsibility into the business and management system across four aspects: environment, labour and human rights, ethics and sustainable procurement.
Our corporate social responsibility strategy focuses on two priorities
Protecting Our Environment
The Company is committed to reducing its greenhouse gas (GHG) emissions and to protecting the environment in which we operate. We believe it is our responsibility to safeguard the environment and strive for continuous improvement to minimise the impact of our operations. To further our progress towards achieving Net Zero by 2050, Kent-Athlone Pharma Group has adopted the target of lowering scope 1 and 2 emissions by 20% and scope 3 emissions by 10% by 2029. This initiative aims to reduce total emissions to 27,484 CO₂e.
[Carbon Reduction Plan
\
We are committed to achieving Net Zero emissions by 2050
Completed Carbon Reduction Initiatives
- Supply chain transition for efficient management and waste reduction
- Implementation of Blue Yonder warehouse management system in the UK 3PL
- Sustainable business travel options
- Including participation in a carbon off-setting programme and a fleet of electric and hybrid company cars
- Waste management
- Established partnerships with suppliers offering carbon off-setting services
Future Carbon Reduction Initiatives
- Become signatories of the United Nations Global Compact
- Align business operations with the UNDP Sustainable Development Goals
- Transition to renewable energy sources
- To increase our use of renewable energy sources by 50% by 2030
- Assess GHG Scope 3 emissions
- Through the engagement of a third-party entity
Our Commitment to Preventing Modern Slavery
As part of the pharmaceutical sector, we recognise the importance of taking a strong stance against slavery and human trafficking. The Company is committed to preventing slavery and human trafficking in all forms, both within our operations and throughout our supply chains. This commitment is evident in our adherence to the principles of the UN Global Compact, our alignment with the UNDP Sustainable Development Goals, and our EcoVadis accreditation in 2025.
[Modern Slavery & Human Trafficking Statement
\
Kent-Athlone Pharma Group is committed to acting in the best interests of the global community in which it operates, ensuring that all applicable legislation, regulations, Codes of Conduct, and industry best practice are adhered to.
Terry Petersen, CEO
Thank you for your interest in our products/services
Important notice: This information on Kent Pharma’s products/services is intended for UK healthcare professionals only.
By proceeding with accessing the product list, you are confirming that you are a UK healthcare professional, and that you wish to access promotional information regarding our Over-Labelling products and services, which is presented if you choose to click through to the next stage.